Dumont & Blake Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.05M | Sell |
12,139
-994
| -8% | -$214K | 0.69% | 36 |
|
|
2026
Q1 | $2.86M | Sell |
13,133
-210
| -2% | -$46.6K | 0.71% | 35 |
|
|
2025
Q4 | $3.05M | Sell |
13,343
-202
| -1% | -$46K | 0.73% | 28 |
|
|
2025
Q3 | $3.14M | Sell |
13,545
-304
| -2% | -$61.9K | 0.76% | 26 |
|
|
2025
Q2 | $2.57M | Sell |
13,849
-40
| -0.3% | -$7.43K | 0.67% | 35 |
|
|
2025
Q1 | $2.91M | Sell |
13,889
-99
| -0.7% | -$19.2K | 0.82% | 25 |
|
|
2024
Q4 | $2.49M | Sell |
13,988
-115
| -0.8% | -$21.1K | 0.67% | 34 |
|
|
2024
Q3 | $2.79M | Sell |
14,103
-14,309
| -50% | -$2.67M | 0.74% | 32 |
|
|
2024
Q2 | $4.87M | Buy |
28,412
+12,786
| +82% | +$2.12M | 0.69% | 34 |
|
|
2024
Q1 | $2.85M | Sell |
15,626
-466
| -3% | -$80.3K | 0.82% | 26 |
|
|
2023
Q4 | $2.49M | Sell |
16,092
-1,347
| -8% | -$196K | 0.77% | 29 |
|
|
2023
Q3 | $2.6M | Sell |
17,439
-47
| -0.3% | -$6.9K | 0.88% | 23 |
|
|
2023
Q2 | $2.36M | Sell |
17,486
-1,115
| -6% | -$164K | 0.77% | 31 |
|
|
2023
Q1 | $2.96M | Sell |
18,601
-75
| -0.4% | -$11.5K | 1% | 16 |
|
|
2022
Q4 | $3.02M | Sell |
18,676
-237
| -1% | -$36.3K | 1.07% | 16 |
|
|
2022
Q3 | $2.54M | Sell |
18,913
-1,060
| -5% | -$152K | 0.95% | 20 |
|
|
2022
Q2 | $3.06M | Sell |
19,973
-138
| -0.7% | -$21.1K | 1% | 20 |
|
|
2022
Q1 | $3.26M | Sell |
20,111
-477
| -2% | -$69.3K | 0.89% | 23 |
|
|
2021
Q4 | $2.79M | Buy |
20,588
+373
| +2% | +$44.1K | 0.73% | 33 |
|
|
2021
Q3 | $2.18M | Buy |
20,215
+21
| +0.1% | +$2.4K | 0.62% | 42 |
|
|
2021
Q2 | $2.27M | Buy |
20,194
+114
| +0.6% | +$12.8K | 0.65% | 40 |
|
|
2021
Q1 | $2.17M | Buy |
20,080
+14
| +0.1% | +$1.5K | 0.67% | 39 |
|
|
2020
Q4 | $2.15M | Sell |
20,066
-924
| -4% | -$88.8K | 0.73% | 34 |
|
|
2020
Q3 | $1.84M | Buy |
20,990
+452
| +2% | +$42.6K | 0.7% | 38 |
|
|
2020
Q2 | $2.02M | Buy |
20,538
+91
| +0.4% | +$8.01K | 0.84% | 31 |
|
|
2020
Q1 | $1.56M | Sell |
20,447
-195
| -0.9% | -$16.6K | 0.8% | 36 |
|
|
2019
Q4 | $1.83M | Buy |
20,642
+150
| +0.7% | +$12.5K | 0.72% | 41 |
|
|
2019
Q3 | $1.55M | Sell |
20,492
-665
| -3% | -$45.6K | 0.65% | 42 |
|
|
2019
Q2 | $1.54M | Buy |
21,157
+90
| +0.4% | +$7.07K | 0.64% | 41 |
|
|
2019
Q1 | $1.7M | Sell |
21,067
-55
| -0.3% | -$4.5K | 0.72% | 37 |
|
|
2018
Q4 | $1.95M | Sell |
21,122
-1,245
| -6% | -$109K | 0.91% | 27 |
|
|
2018
Q3 | $2.12M | Buy |
22,367
+822
| +4% | +$78K | 0.82% | 31 |
|
|
2018
Q2 | $2M | Sell |
21,545
-1,750
| -8% | -$171K | 0.84% | 33 |
|
|
2018
Q1 | $2.21M | Buy |
23,295
+25
| +0.1% | +$2.75K | 0.94% | 25 |
|
|
2017
Q4 | $2.25M | Hold |
23,270
| – | – | 0.91% | 25 |
|
|
2017
Q3 | $2.07M | Sell |
23,270
-300
| -1% | -$22.8K | 0.89% | 29 |
|
|
2017
Q2 | $1.71M | Buy |
23,570
+1,875
| +9% | +$126K | 0.76% | 38 |
|
|
2017
Q1 | $1.41M | Buy |
21,695
+120
| +0.6% | +$7.54K | 0.64% | 44 |
|
|
2016
Q4 | $1.35M | Buy |
21,575
+20
| +0.1% | +$1.22K | 0.63% | 47 |
|
|
2016
Q3 | $1.36M | Sell |
21,555
-200
| -0.9% | -$12.9K | 0.67% | 44 |
|
|
2016
Q2 | $1.35M | Sell |
21,755
-600
| -3% | -$36.6K | 0.68% | 44 |
|
|
2016
Q1 | $1.28M | Sell |
22,355
-175
| -0.8% | -$9.75K | 0.66% | 46 |
|
|
2015
Q4 | $1.33M | Buy |
22,530
+850
| +4% | +$49K | 0.68% | 45 |
|
|
2015
Q3 | $1.18M | Hold |
21,680
| – | – | 0.64% | 54 |
|
|
2015
Q2 | $1.46M | Buy |
21,680
+1,375
| +7% | +$89.8K | 0.71% | 48 |
|
|
2015
Q1 | $1.19M | Buy |
20,305
+100
| +0.5% | +$6.04K | 0.58% | 66 |
|
|
2014
Q4 | $1.32M | Sell |
20,205
-200
| -1% | -$12.6K | 0.65% | 57 |
|
|
2014
Q3 | $1.18M | Sell |
20,405
-150
| -0.7% | -$8.33K | 0.61% | 62 |
|
|
2014
Q2 | $1.16M | Sell |
20,555
-675
| -3% | -$35.4K | 0.58% | 67 |
|
|
2014
Q1 | $1.09M | Sell |
21,230
-390
| -2% | -$19.7K | 0.57% | 69 |
|
|
2013
Q4 | $1.14M | Sell |
21,620
-1,315
| -6% | -$64.6K | 0.59% | 67 |
|
|
2013
Q3 | $1.03M | Sell |
22,935
-65
| -0.3% | -$2.88K | 0.49% | 85 |
|
|
2013
Q2 | $951K | Buy |
+23,000
| New | +$1.01M | 0.57% | 74 |
|
Other funds holding ABBV
Dumont & Blake Investment Advisors's ABBV Position: Q2 2026 in Review
Dumont & Blake Investment Advisors reduced its AbbVie (ABBV) stake by 7.6% in Q2 2026, selling an estimated $214K and leaving 12,139 shares worth $3.05M. The position accounts for 0.69% of the portfolio, ranked #36.
Dumont & Blake Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.87M in Q2 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Dumont & Blake Investment Advisors held 12,139 shares of AbbVie worth $3.05M as of Q2 2026.
- Dumont & Blake Investment Advisors sold 994 AbbVie shares in Q2 2026, an estimated $214K.
- AbbVie made up 0.69% of Dumont & Blake Investment Advisors's portfolio in Q2 2026, its #36 holding.
- Dumont & Blake Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Dumont & Blake Investment Advisors's AbbVie position peaked at $4.87M in Q2 2024.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Dumont & Blake Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.